Cisplatin과 보정방암탕에 의한 백서 사구체 혈관사이세포의 세포사멸 기전 연구
Machanism of Cisplatin-induced Apoptosis and Bojungbangam-tang-mediated Anti-apoptotic Effect on Cell Proliferation in Rat Mesangial Cells
2
조회
0
다운로드
2
인용
0
참고문헌
키워드
초록
Cisplatin is a anti-neoplastic agent which is commonly used for the treatment of solid tumor. Cisplatin activates multiple signal transduction pathways involved in the stress-induced apoptosis in a variety of cell types. Previous study reported that cisplatin induces apoptosis through activation of ERK, p38 and JNK in rat mesangial cells, but apoptotic pathway remain known. The present study investigated the apoptotic pathway for cisplatin-indcued apoptosis in rat mesangial cells. cisplatin-induced apoptosis was associated with activation of caspase-3, caspase-8, caspase-9. Caspase-8 inhibition prevented the activation of both caspase-3 and caspase-9. In addition, cisplatin-induced apoptosis increased the expression of Bax, but not the level of Bcl-2. These change of Bax/bcl-2 ratio caused the release of cytochrome c from mitochondria into cytosol. In previous study, the ethanol extract of Bojungbangam-tang (EBJT) inhibited cisplatin-induced apoptosis in rat mesangial cells through inhibition of ERK and JNK activation. However, EBJT did not increase cell proliferation, because it did not prevent cisplatin-induced G2/M phase arrest. These effect of EBJT may be related to p38 activation. Cisplatin-induced G2/M phase arrest are inhibited by treatment with p38 inhibitor and EBJT in rat mesangial cells. Also, p38 inhibition and EBJT treatment on cisplatin-induced G2/M phase arrest are markedly increased the G0/G1 phase and reduced the sub-G1. In conclusion, anti-apoptotic effet of EBJT did not increases cell proliferation, because EBJT did not reduce p38 activation related to cisplatin-induced G2/M phase arrest.
Abstract
Cisplatin is a anti-neoplastic agent which is commonly used for the treatment of solid tumor. Cisplatin activates multiple signal transduction pathways involved in the stress-induced apoptosis in a variety of cell types. Previous study reported that cisplatin induces apoptosis through activation of ERK, p38 and JNK in rat mesangial cells, but apoptotic pathway remain known. The present study investigated the apoptotic pathway for cisplatin-indcued apoptosis in rat mesangial cells. cisplatin-induced apoptosis was associated with activation of caspase-3, caspase-8, caspase-9. Caspase-8 inhibition prevented the activation of both caspase-3 and caspase-9. In addition, cisplatin-induced apoptosis increased the expression of Bax, but not the level of Bcl-2. These change of Bax/bcl-2 ratio caused the release of cytochrome c from mitochondria into cytosol. In previous study, the ethanol extract of Bojungbangam-tang (EBJT) inhibited cisplatin-induced apoptosis in rat mesangial cells through inhibition of ERK and JNK activation. However, EBJT did not increase cell proliferation, because it did not prevent cisplatin-induced G2/M phase arrest. These effect of EBJT may be related to p38 activation. Cisplatin-induced G2/M phase arrest are inhibited by treatment with p38 inhibitor and EBJT in rat mesangial cells. Also, p38 inhibition and EBJT treatment on cisplatin-induced G2/M phase arrest are markedly increased the G0/G1 phase and reduced the sub-G1. In conclusion, anti-apoptotic effet of EBJT did not increases cell proliferation, because EBJT did not reduce p38 activation related to cisplatin-induced G2/M phase arrest.
참고문헌 (32)
- Timmer-Bosscha, H., "Modulation of cis-diamminedichloroplatinum(II) resistance: a review", Br. J. Cancer, 66, pp.227~238 (1992)
- Goldstein, R. S., "Minireview. The nephrotoxicity of cisplatin", Life Sci, 32, pp.685~690 (1983)
- Safirstein, R., "Cisplatin nephrotoxicity", Am. J. Kidney Dis, 8, pp.356~367 (1986)
- Eastman, A., "The formation, isolation and characterization of DNA adducts produced by anticancer platinum complexes", Pharmacol. Ther, 34, pp.155~166 (1987)
- Siddik, Z. H, "Cisplatin : mode of cytotoxic action and molecular basis of resistance", Oncogene, 22, pp.7265~7279 (2003)
- 김남수, "Anti-apoptotic Effect of Bojungbangam-tang Ethanol Extract on Cisplatin-Induced Apoptosis in Rat Mesangial Cells", 동의생리병리학회지, 20(6), pp.1664~1671 (2006), 대한동의병리학회
- Céraline, J., "Inactivation of p53 in normal human cells increases G2", M arrest and sensitivity to DNA-damaging agents, 1998, pp.75, 432~438
- Zhou, H., "The induction of cell cycle regulatory and DNA repair proteins in cisplatin-induced acute renal failure", Toxicol. Appl. Pharmacol, 200, pp.111~120 (2004)
- Guadagno, T. M., "Requirement for MAPK activation for normal mitotic progression in Xenopus egg extracts", Science, 282, pp.1312~1315 (1998)
- Wright, J. H., "Mitogen-activated protein kinase kinase activity is required for the G(2)", M transition of the cell cycle in mammalian fibroblasts, 1999, pp.96, 11335~11340
- Bulavin, D. V., "Initiation of a G2", M checkpoint after ultraviolet radiation requires p38 kinase, 2001, pp.411, 102~107
- Wang, X., "Involvement of the MKK6-p38gamma cascade in gamma-radiation-induced cell cycle arrest", Mol. Cell Biol, 20, pp.4543~4552 (2000)
- Pae, H. O., "Imperatorin, a furanocoumarin from Angelica dahurica (Umbelliferae), induces cytochrome c-dependent apoptosis in human promyelocytic leukaemia, HL-60 Cells", Pharmacol. Toxicol, 91, pp.40~48 (2002)
- Kroemer, G., "Mitochondrial control of apoptosis", Immunol. Today, 18, pp.44~51 (1997)
- Mignotte, B., "Mitochondria and apoptosis", Eur. J. Biochem, 252, pp.1~15 (1998)
- Zou, H., "An APAF-1.cytochrome c multimeric complex is a functional apoptosome that activates procaspase-9", J. Biol. Chem, 274, pp.11549~11558 (1999)
- Kaufmann, S. H., "Programmed cell death: alive and well in the new millennium", Trends Cell. Biol, 11, pp.526~534 (2001)
- Hengartner, M. O, "The biochemistry of apoptosis", Nature, 407, pp.770~776 (2000)
- Boldin, M. P., "Involvement of MACH, a novel MORT1", FADD-interacting protease, in Fas, Cell, pp.1996, 85[DOI]
- Kischkel, F. C., "Cytotoxicity-dependent APO-1 (Fas", CD95)-associated proteins form a death-inducing signaling complex (DISC) with the receptor, 1995, pp.14, 5579~5588
- Chandra, D., "Early mitochondrial activation and cytochrome c up-regulation during apoptosis", J, Biol. Chem, 277, pp.50842~50854 (2002)
- Green, D. R., "Mitochondria and apoptosis", Science, 281, pp.1309~1312 (1998)
- Zou, H., "Apaf-1, a human protein homologous to C. elegans CED-4, participates in cytochrome c-dependent activation of caspase-3", Cell, 90, pp.405~413 (1997)
- Hsu, Y. T., "Bax in murine thymus is a soluble monomeric protein that displays differential detergent-induced conformations", J. Biol. Chem, 273, pp.10777~10783 (1998)
- Murphy, K, M., "Bax membrane insertion during Fas(CD95)-induced apoptosis precedes cytochrome c release and is inhibited by Bcl-2", Oncogene, 18, pp.5991~5999 (1999)
- Gross, A., "BCL-2 family members and the mitochondria in apoptosis", Genes Dev, 13, pp.1899~1911 (1999)
- Pastorino, J. G., "The overexpression of Bax produces cell death upon induction of the mitochondrial permeability transition", J. Biol. Chem, 273, pp.7770~7775 (1998)
- Wei, M. C., "Proapoptotic BAX and BAK : a requisite gateway to mitochondrial dysfunction and death", Science, 292, pp.727~730 (2001)
- Finucane, D. M., "Bax-induced caspase activation and apoptosis via cytochrome c release from mitochondria is inhibitable by Bcl-xL", J. Biol. Chem, 274, pp.2225~2233 (1999)
- Johnson, B. W., "Bcl-xL inhibits cytochrome c release but not mitochondrial depolarization during the activation of multiple death pathways by tumor necrosis factor-alpha", J. Biol. Chem, 275, pp.31546~31553 (2000)
- Kluck, R. M., "The release of cytochrome c from mitochondria : a primary site for Bcl-2 regulation of apoptosis", Science, 275, pp.1081~1082 (1997)
- Kim, H. J., "Bax-dependent apoptosis induced by ceramide in HL-60 cells", FEBS Lett, 505, pp.264~268 (2001)